Literature DB >> 11263558

Procalcitonin increase after anti-CD3 monoclonal antibody therapy does not indicate infectious disease.

E R Kuse, K Jaeger.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11263558     DOI： 10.1007/s001470050744

Source DB:  PubMed          Journal:  Transpl Int        ISSN： 0934-0874            Impact factor:   3.782


× No keyword cloud information.
  4 in total

1.  Role of biomarkers in early infectious complications after lung transplantation.

Authors:  Borja Suberviola; Luzdivina Rellan; Jordi Riera; Reyes Iranzo; Ascension Garcia Campos; Juan Carlos Robles; Rosario Vicente; Eduardo Miñambres; Miguel Santibanez
Journal:  PLoS One       Date:  2017-07-13       Impact factor: 3.240

2.  Marked increase of procalcitonin after the administration of anti-thymocyte globulin in patients before hematopoietic stem cell transplantation does not indicate sepsis: a prospective study.

Authors:  Helena Brodska; Tomas Drabek; Karin Malickova; Antonin Kazda; Antonin Vitek; Tomas Zima; Marketa Markova
Journal:  Crit Care       Date:  2009-03-16       Impact factor: 9.097

3.  Induction of procalcitonin in liver transplant patients treated with anti-thymocyte globulin.

Authors:  Roman Zazula; Miroslav Prucha; Tomas Tyll; Eva Kieslichova
Journal:  Crit Care       Date:  2007       Impact factor: 9.097

4.  Procalcitonin in liver transplant patients--yet another stone turned.

Authors:  Jens-Ulrik Jensen; Jens D Lundgren
Journal:  Crit Care       Date:  2008-01-22       Impact factor: 9.097
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.